Analysis of Bevacizumab-Induced Gastrointestinal Perforation Using the Japanese Adverse Drug Event Report Database
In non-small cell lung cancer, the time to BIGP onset is earlier than that in colorectal and ovarian cancers. This finding suggests that healthcare providers can detect and intervene BIGP at early stages.
Authors
- Hirofumi Tamaki (ORCID: https://orcid.org/0000-0002-4543-1176)
- Moe Yamashita
- Mika Maezawa (ORCID: https://orcid.org/0000-0002-9166-1351)
- Kazuya Nonomura
- Kazuhiro Iguchi (ORCID: https://orcid.org/0000-0003-1506-9804)
- Tomofumi Yamazaki
- Koumi Miyasaka
- Mitsuhiro Nakamura (ORCID: https://orcid.org/0000-0002-6406-2097)
- Yuka Nokura
- Satoshi Nakao (ORCID: https://orcid.org/0000-0001-7413-2637)
- Hideyuki Tanaka
- Sakiko Hirofuji
- Nanaka Ichihara
- Kana Sugishita
Institutions
- Gifu Pharmaceutical University (JP)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-05
- DOI
- https://doi.org/10.7759/cureus.78585
- Citations
- 1
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Japan Society for the Promotion of Science